AFP-L3 for the diagnosis of early hepatocellular carcinoma

Serum levels of circulating microRNA-107 are elevated in patients with early-stage HCC

(2021) Sven H. Loosen et al.   PLoS One

Serum Biomarkers for the Prediction of Hepatocellular Carcinoma

(2021) José Debes et al.   Cancers

Diagnostic value of serum glypican-3 alone and in combination with AFP as an aid in the diagnosis of liver cancer

(2020) Shuxia Liu et al.   CLINICAL BIOCHEMISTRY

Emerging biomarkers in HCC patients: Current status

(2020) Hugo Pinto Marques et al.   International Journal of Surgery

Serum pentraxin 3 as a biomarker of hepatocellular carcinoma in chronic hepatitis B virus infection

(2020) Huan Deng et al.   Scientific Reports

GALAD Score Detects Early Hepatocellular Carcinoma in an International Cohort of Patients With Nonalcoholic Steatohepatitis

(2019) Jan Best et al.   Clinical Gastroenterology and Hepatology

Diagnostic value of alpha-1-fetoprotein (AFP) as a biomarker for hepatocellular carcinoma recurrence after liver transplantation

(2018) Aventinus Nörthen et al.   CLINICAL BIOCHEMISTRY

Clinical Assay for AFP-L3 by Using Multiple Reaction Monitoring–Mass Spectrometry for Diagnosing Hepatocellular Carcinoma

(2018) Hyunsoo Kim et al.   CLINICAL CHEMISTRY

Diagnosis and staging of hepatocellular carcinoma (HCC): current guidelines

(2018) Carmen Ayuso et al.   EUROPEAN JOURNAL OF RADIOLOGY

New hallmark of hepatocellular carcinoma, early hepatocellular carcinoma and high-grade dysplastic nodules on Gd-EOB-DTPA MRI in patients with cirrhosis: a new diagnostic algorithm

(2018) Matteo Renzulli et al.   GUT

EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma

(2018) Peter R. Galle et al.   JOURNAL OF HEPATOLOGY

Direct comparison of five serum biomarkers in early diagnosis of hepatocellular carcinoma

(2018) Hongda Chen et al.   Cancer Management and Research

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2018) Freddie Bray et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Diagnostic value of serum PIVKA-II levels for BCLC early hepatocellular carcinoma and correlation with HBV DNA

(2018) Jiali Wu et al.   Cancer Biomarkers

Longitudinal Assessment of Three Serum Biomarkers to Detect Very Early Stage Hepatocellular Carcinoma

(2018) Jonggi Choi et al.   HEPATOLOGY

Electrochemical Assay of the Alpha Fetoprotein-L3 Isoform Ratio To Improve the Diagnostic Accuracy of Hepatocellular Carcinoma

(2018) Tianxiang Wei et al.   ANALYTICAL CHEMISTRY

Imaging for the diagnosis of hepatocellular carcinoma: A systematic review and meta-analysis

(2017) Lewis R. Roberts et al.   HEPATOLOGY

Artificial neural network models for early diagnosis of hepatocellular carcinoma using serum levels of α-fetoprotein, α-fetoprotein-L3, des-γ-carboxy prothrombin, and Golgi protein 73

(2017) Bo Li et al.   Oncotarget

Controversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinoma

(2016) Pei-Pei Song   WORLD JOURNAL OF GASTROENTEROLOGY

The GALAD scoring algorithm based on AFP, AFP-L3, and DCP significantly improves detection of BCLC early stage hepatocellular carcinoma

(2016) J. Best et al.   ZEITSCHRIFT FUR GASTROENTEROLOGIE

A Chemiluminescent Protein Microarray Method for Determining the Seroglycoid Fucosylation Index

(2016) Aiying Zhang et al.   Scientific Reports

Plasma miRNAs as early biomarkers for detecting hepatocellular carcinoma

(2015) Yang Wen et al.   INTERNATIONAL JOURNAL OF CANCER

Combined use of AFP, PIVKA-II, and AFP-L3 as tumor markers enhances diagnostic accuracy for hepatocellular carcinoma in cirrhotic patients

(2015) Tae Seop Lim et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Alpha-fetoprotein-L3 in hepatocellular carcinoma: A meta-analysis

(2013) Xiaoyan Yi et al.   CLINICA CHIMICA ACTA

Annexin A2 is a discriminative serological candidate in early hepatocellular carcinoma

(2012) Yulin Sun et al.   CARCINOGENESIS

Hepatocellualar Carcinoma Serum Markers

(2012) Gaetano Bertino et al.   SEMINARS IN ONCOLOGY

Elevated serum levels of Chromogranin A in hepatocellular carcinoma

(2012) Antonio Biondi et al.   BMC Surgery

Management of Hepatocellular Carcinoma in Japan: Consensus-Based Clinical Practice Guidelines Proposed by the Japan Society of Hepatology (JSH) 2010 Updated Version

(2011) Masatoshi Kudo et al.   DIGESTIVE DISEASES

Identification of osteopontin as a novel marker for early hepatocellular carcinoma

(2011) Sufen Shang et al.   HEPATOLOGY

Highly sensitive AFP-L3% assay is useful for predicting recurrence of hepatocellular carcinoma after curative treatment pre- and postoperatively

(2011) Masahiro Kobayashi et al.   HEPATOLOGY RESEARCH

Clinical Advantage of Highly Sensitive On-Chip Immunoassay for Fucosylated Fraction of Alpha-Fetoprotein in Patients with Hepatocellular Carcinoma

(2010) Yasushi Tamura et al.   DIGESTIVE DISEASES AND SCIENCES

AFP, AFP-L3, DCP, and GP73 as markers for monitoring treatment response and recurrence and as surrogate markers of clinicopathological variables of HCC

(2010) Kentaroh Yamamoto et al.   JOURNAL OF GASTROENTEROLOGY

Lens culinaris agglutinin-reactive fraction of AFP is a useful prognostic biomarker for survival after repeat hepatic resection for HCC

(2010) Masanori Matsuda et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

α-Fetoprotein, Des-γ Carboxyprothrombin, and Lectin-Bound α-Fetoprotein in Early Hepatocellular Carcinoma

(2009) Jorge A. Marrero et al.   GASTROENTEROLOGY